home / press / releases

Menu
  • Search all tables

releases: https://www.king.senate.gov/newsroom/press-releases/king-announces-proposal-to-create-national-mail-back-drug-program

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.king.senate.gov/newsroom/press-releases/king-announces-proposal-to-create-national-mail-back-drug-program King Announces Proposal to Create National Mail-Back Drug Program 2015-11-24 2015 2015-11 Independent House ME Angus King K000383 www.king.senate.gov     legacy King Announces Proposal to Create National Mail-Back Drug Program Based on successful Maine pilot program, proposal seeks to make getting rid of excess prescription drugs easier, helping better protect public health and safety across the state Tuesday, November 24, 2015 PORTLAND, ME During a roundtable discussion today focused on how the federal government can close the prescription painkillers to opioid addiction gateway, U.S. Senator Angus King (I-Maine) announced a new federal proposal that would help people across the country more quickly, safely, and responsibly dispose of excess prescription drugs. During the discussion, Senator King also announced his support for bipartisan legislation that would expand specialized treatment for prescription drug and heroin addiction. Opioid addiction knows no bounds. It can grip anyone at any time, and sadly, in more cases than not, it starts at home with an unsuspecting pain medication meant to help someone,Senator King said. Today, there are far too many of those painkillers sitting unused in homes across this country, and the longer they do, the more serious a risk they pose to peoples health and safety. The federal government needs to work more closely with doctors to curb the number of drugs unnecessarily provided on the front end, and then work to ensure theres an easy and responsible way to dispose of excess drugs on the back end as well. I believe a drug mail-back program holds the potential to helppeople moreeasily and safely dispose of their unwanted medications, and I will engage with people to see how the government can best accomplish that goal. The proposal announced by Senator King today would create a national program that builds on the successful Maine pilot project known as Safe Medicine Disposal for ME, which allowed people to mail back their unused prescription drugs to Maine DEA.Currently, federal regulations allow pharmacies, hospitals, clinics, and other authorized collectors to serve as collection points for unused prescription medications, and special events like National Prescription Drug Take-Back day, also aim to provide a responsible means for the disposal of unneededdrugs. However, those methods, while very useful, can still be an obstacle to the disposal of unwanted drugs, particularly in rural areas and for people with limited access to transportation. Senator Kings proposal would streamline the process by allowing people to directly mail back excess drugs from their homes, thereby getting them off medicinecabinet shelves and reducing the hazard posed to health and safety. During the discussion, Senator King also announced his supportthe Recovery Enhancement for Addiction Treatment (TREAT) Act of 2015, bipartisan legislation that would expand specialized treatment for prescription drug and heroin addiction. Introduced by Senators Ed Markey (D-Mass.) and Senator Rand Paul (R-Ky.), the legislation would expand the ability of addiction medical specialists and other trained medical professionals to provide life-saving medication-assisted therapies such as buprenorphine (also called Suboxone) for patients battling heroin and prescription drug addiction. Unfortunately, due in part to federal restrictions, of the approximately 2.4 million people dealing with prescription drug and heroin dependency in 2013, only half received specialty treatment for their condition. More specifically,the TREAT Actwould help increase the number of patients who have access to treatment by allowing substance abuse treatment specialists and certain other trained physicians who are practicing in a team-based facility that has built in quality measures to see a greater number of patients. Physicians under the bill are also required to fully participate in state-based prescription drug monitoring databases to track prescription drug use. The bill would also allow trained nurse practitioners and physician assistants to treat, for the first time, opioid dependent patients with approved medication assisted treatments. Combined with behavioral therapy, effective medication assisted treatment programs for opioid addiction can decrease overdose deaths, be cost-effective, reduce transmissions of HIV and hepatitis C, and reduce other social harms such as criminal activity. While emphasizing addiction medicine expertise and quality, the legislation lifts existing and arbitrary federal restrictions that are non-existent for any other disease and limit access to life saving therapies. For more information on the bill, clickHERE. Senator Kings mail-back proposal, which he will continue to gather feedback on in the coming weeks and then introduce as legislation, along with his support ofthe TREAT Act, represent a two-pronged approach to closing the gateway from prescription painkiller use and abuse to opioid addiction. Senator Kings roundtable today followed aninitial roundtablediscussion last August on the opioid epidemic in Maine and focused more specifically on the use and abuse of prescription painkillers as a gateway to addiction. According to the Office of National Drug Control Policy, four in five heroin users started out by misusing prescription opioid pain medications. Additionally, according to the Centers for Disease Control and Prevention (CDC), 44 people in the U.S. die each day from an overdose of prescription pain medication. ### 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.659ms · Data license: MIT · Data source: dwillis/congress-press